Back to search

Article

Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical Study

2021-04-07

Abstract excerpt

<h4>Aims</h4> Cardiomyocyte-derived induced pluripotent stem cells (iPSCs) may represent a promising therapeutic strategy for severely damaged myocardium. This study aimed to assess the efficacy and safety of clinical grade human iPSC-derived cardiomyocyte (hiPSC-CM) patches and conduct a pre-clinical proof-of-concept analysis. <h4>Methods and results</h4> A clinical grade hiPSC line was established from periphe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95ae0206-93dd-535e-8476-ba6842e6bab8
DOI
10.1101/2021.04.07.438744
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical StudyDOI 10.1101/2021.04.07.438744
Select a neighboring publication to make it the new centre.